The Cigna Group (NYSE:CI) Shares Sold by Bruni J V & Co. Co.

Bruni J V & Co. Co. decreased its position in The Cigna Group (NYSE:CIFree Report) by 0.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 108,355 shares of the health services provider’s stock after selling 395 shares during the quarter. The Cigna Group comprises approximately 4.0% of Bruni J V & Co. Co.’s holdings, making the stock its 11th largest position. Bruni J V & Co. Co.’s holdings in The Cigna Group were worth $32,447,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CI. Strategic Blueprint LLC raised its holdings in The Cigna Group by 4.8% during the 3rd quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock worth $224,000 after buying an additional 36 shares during the period. Simplicity Solutions LLC grew its holdings in shares of The Cigna Group by 17.4% during the third quarter. Simplicity Solutions LLC now owns 8,030 shares of the health services provider’s stock valued at $2,297,000 after buying an additional 1,189 shares in the last quarter. Ropes Wealth Advisors LLC grew its stake in The Cigna Group by 31.5% during the 3rd quarter. Ropes Wealth Advisors LLC now owns 1,557 shares of the health services provider’s stock valued at $445,000 after acquiring an additional 373 shares in the last quarter. Avestar Capital LLC increased its holdings in shares of The Cigna Group by 0.8% in the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock valued at $1,312,000 after purchasing an additional 35 shares during the period. Finally, Lake Street Financial LLC boosted its holdings in shares of The Cigna Group by 6.8% during the third quarter. Lake Street Financial LLC now owns 9,637 shares of the health services provider’s stock worth $2,798,000 after purchasing an additional 612 shares during the period. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the subject of a number of research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $384.00 target price on shares of The Cigna Group in a research note on Wednesday, April 10th. Sanford C. Bernstein upgraded The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Royal Bank of Canada upgraded shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their target price for the company from $327.00 to $354.00 in a research note on Monday, February 5th. Mizuho raised their price target on shares of The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a report on Monday, February 5th. Finally, StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $362.14.

View Our Latest Stock Analysis on CI

Insiders Place Their Bets

In related news, insider Eric P. Palmer sold 1,017 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $335.26, for a total value of $340,959.42. Following the completion of the transaction, the insider now owns 45,564 shares in the company, valued at approximately $15,275,786.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Eric P. Palmer sold 1,017 shares of the stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $335.26, for a total value of $340,959.42. Following the transaction, the insider now directly owns 45,564 shares in the company, valued at $15,275,786.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 31,209 shares of The Cigna Group stock in a transaction on Monday, March 25th. The stock was sold at an average price of $355.17, for a total transaction of $11,084,500.53. Following the sale, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at approximately $123,618,339.18. The disclosure for this sale can be found here. Insiders have sold a total of 114,144 shares of company stock valued at $39,296,330 in the last 90 days. 0.60% of the stock is currently owned by insiders.

The Cigna Group Price Performance

Shares of The Cigna Group stock traded down $0.04 during mid-day trading on Friday, reaching $354.47. 830,527 shares of the stock were exchanged, compared to its average volume of 1,260,787. The Cigna Group has a fifty-two week low of $240.50 and a fifty-two week high of $365.71. The company has a market cap of $103.63 billion, a price-to-earnings ratio of 20.38, a price-to-earnings-growth ratio of 1.09 and a beta of 0.56. The firm has a 50-day simple moving average of $349.88 and a 200 day simple moving average of $317.98. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.61.

The Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The business had revenue of $51.15 billion for the quarter, compared to analyst estimates of $48.91 billion. During the same period in the prior year, the company earned $4.96 EPS. The Cigna Group’s revenue for the quarter was up 11.8% on a year-over-year basis. On average, sell-side analysts predict that The Cigna Group will post 28.36 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be given a dividend of $1.40 per share. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 annualized dividend and a yield of 1.58%. The Cigna Group’s dividend payout ratio (DPR) is 32.20%.

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.